These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 28473227

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the Impact of Excipients and an Albendazole Salt on Albendazole Concentrations in Upper Small Intestine Using an In Vitro Biorelevant Gastrointestinal Transfer (BioGIT) System.
    Kourentas A, Vertzoni M, Khadra I, Symillides M, Clark H, Halbert G, Butler J, Reppas C.
    J Pharm Sci; 2016 Sep; 105(9):2896-2903. PubMed ID: 27372549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base albendazole and its main metabolite albendazole sulfoxide.
    Pettarin M, Bolger MB, Chronowska M, Kostewicz ES.
    Eur J Pharm Sci; 2020 Dec 01; 155():105552. PubMed ID: 32937212
    [Abstract] [Full Text] [Related]

  • 9. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
    Higashino H, Hasegawa T, Yamamoto M, Matsui R, Masaoka Y, Kataoka M, Sakuma S, Yamashita S.
    Mol Pharm; 2014 Mar 03; 11(3):746-54. PubMed ID: 24460473
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations.
    Pradines B, Gallard JF, Iorga BI, Gueutin C, Loiseau PM, Ponchel G, Bouchemal K.
    Carbohydr Res; 2014 Oct 29; 398():50-5. PubMed ID: 25240182
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Developing a Formulation Strategy Coupled with PBPK Modeling and Simulation for the Weakly Basic Drug Albendazole.
    Shah H, Shah K, Gajera B, Dave RH, Taft DR.
    Pharmaceutics; 2023 Mar 23; 15(4):. PubMed ID: 37111526
    [Abstract] [Full Text] [Related]

  • 18. Coumestrol/hydroxypropyl-β-cyclodextrin association incorporated in hydroxypropyl methylcellulose hydrogel exhibits wound healing effect: in vitro and in vivo study.
    Bianchi SE, Machado BEK, da Silva MGC, da Silva MMA, Bosco LD, Marques MS, Horn AP, Persich L, Geller FC, Argenta D, Teixeira HF, Simões CMO, Dora CL, Bassani VL.
    Eur J Pharm Sci; 2018 Jul 01; 119():179-188. PubMed ID: 29665401
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluating supersaturation in vitro and predicting its performance in vivo with Biphasic gastrointestinal Simulator: A case study of a BCS IIB drug.
    Gan Y, Zhang X, Xu D, Zhang H, Baak JP, Luo L, Xia Y, Wang J, Ke X, Sun P.
    Int J Pharm; 2020 Mar 30; 578():119043. PubMed ID: 31962190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.